Filed before 2025Filed 10 August 2023
ADARx Pharmaceuticals, Inc. raised $200M
ADARx Pharmaceuticals, Inc., a biotech company based in San Diego, CA, raised $200M in a new equity round, according to a filing dated 10 August 2023.
Raises filed before 2025 are not checked for a public announcement.
- Filed
- 10 August 2023
- Round
- Equity round
- Amount sold
- $200M
- Offering size
- $200M
- Investors so far
- 28
- Based in
- San Diego, CA
Investors on the board
- Ascenta Capital
- Ascenta Capital Project Turing
- TCG Crossover
- SR One Capital
- Synapse Investment
- SilverArc
- Sirona Capital
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
5 directors of this company are named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 99% of the 1,396 tracked raises with an amount filed in 2023, and than 99% of the 142 in biotech.
ADARx Pharmaceuticals, Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 10 Aug 2023 | New filing | $200M | This raise |
| 26 Jan 2023 | New filing | $46M | Another raise |
| 17 Aug 2021 | New filing | $75M | Another raise |
| 24 May 2021 | New filing | $15.5M | Another raise |
| 17 Nov 2020 | New filing | $6M | Another raise |
More with Ascenta Capital on the board
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.